arcosa inc - ACA

ACA

Close Chg Chg %
112.97 -2.09 -1.85%

Closed Market

110.88

-2.09 (1.85%)

Volume: 187.30K

Last Updated:

Dec 12, 2025, 3:59 PM EDT

Company Overview: arcosa inc - ACA

ACA Key Data

Open

$112.98

Day Range

109.93 - 113.23

52 Week Range

68.11 - 113.23

Market Cap

$5.44B

Shares Outstanding

49.05M

Public Float

48.16M

Beta

1.00

Rev. Per Employee

N/A

P/E Ratio

37.40

EPS

$3.03

Yield

17.70%

Dividend

$0.05

EX-DIVIDEND DATE

Oct 15, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

238.18K

 

ACA Performance

1 Week
 
3.31%
 
1 Month
 
10.31%
 
3 Months
 
16.42%
 
1 Year
 
1.56%
 
5 Years
 
103.79%
 

ACA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About arcosa inc - ACA

Arcosa, Inc. engages in the provision of infrastructure-related products and services. It operates through the following segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Engineered Structures segment manufactures and sells steel and concrete structures for infrastructure businesses, including utility structures for electricity transmission and distribution, structural wind towers, traffic and lighting structures, and telecommunication structures. The Transportation Products segment covers the manufacture and sale of products for the inland waterway and rail transportation industries, including barges, barge-related products, axles, and couplers. The company was founded on November 1, 2018 and is headquartered in Dallas, TX.

ACA At a Glance

Arcosa, Inc.
500 North Akard Street
Dallas, Texas 75201
Phone 1-972-942-6500 Revenue 2.57B
Industry Construction Materials Net Income 93.40M
Sector Non-Energy Minerals 2024 Sales Growth 11.352%
Fiscal Year-end 12 / 2025 Employees 6,250
View SEC Filings

ACA Valuation

P/E Current 37.403
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 50.546
Price to Sales Ratio 1.837
Price to Book Ratio 1.944
Price to Cash Flow Ratio 9.40
Enterprise Value to EBITDA 15.121
Enterprise Value to Sales 2.446
Total Debt to Enterprise Value 0.279

ACA Efficiency

Revenue/Employee 411,184.00
Income Per Employee 14,944.00
Receivables Turnover 7.338
Total Asset Turnover 0.605

ACA Liquidity

Current Ratio 1.849
Quick Ratio 1.151
Cash Ratio 0.363

ACA Profitability

Gross Margin 20.047
Operating Margin 8.588
Pretax Margin 5.059
Net Margin 3.634
Return on Assets 2.199
Return on Equity 3.924
Return on Total Capital 2.234
Return on Invested Capital 2.637

ACA Capital Structure

Total Debt to Total Equity 72.16
Total Debt to Total Capital 41.915
Total Debt to Total Assets 35.646
Long-Term Debt to Equity 71.308
Long-Term Debt to Total Capital 41.419
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Arcosa Inc - ACA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.04B 2.24B 2.31B 2.57B
Sales Growth
+5.21% +10.14% +2.90% +11.35%
Cost of Goods Sold (COGS) incl D&A
1.67B 1.82B 1.86B 2.05B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
144.30M 154.10M 159.50M 195.00M
Depreciation
- 134.40M 138.60M 168.70M
Amortization of Intangibles
- 19.70M 20.90M 26.30M
COGS Growth
+7.51% +8.97% +2.42% +10.22%
Gross Income
366.20M 422.80M 443.80M 515.20M
Gross Income Growth
-4.14% +15.46% +4.97% +16.09%
Gross Profit Margin
+17.98% +18.85% +19.23% +20.05%
2021 2022 2023 2024 5-year trend
SG&A Expense
256.00M 262.80M 261.10M 294.50M
Research & Development
- - - -
-
Other SG&A
256.00M 262.80M 261.10M 294.50M
SGA Growth
+14.75% +2.66% -0.65% +12.79%
Other Operating Expense
- - - -
-
Unusual Expense
- - 2.90M 31.30M
-
EBIT after Unusual Expense
107.30M 160.00M 182.70M 189.40M
Non Operating Income/Expense
(300.00K) 187.20M 41.30M 11.50M
Non-Operating Interest Income
- 1.10M 4.70M 7.50M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
23.40M 31.00M 28.10M 70.90M
Interest Expense Growth
+120.75% +32.48% -9.35% +152.31%
Gross Interest Expense
23.40M 31.00M 28.10M 70.90M
Interest Capitalized
- - - -
-
Pretax Income
83.60M 316.20M 195.90M 130.00M
Pretax Income Growth
-39.51% +278.23% -38.05% -33.64%
Pretax Margin
+4.11% +14.10% +8.49% +5.06%
Income Tax
14.00M 70.40M 36.70M 36.30M
Income Tax - Current - Domestic
1.50M 19.20M 4.90M 8.30M
Income Tax - Current - Foreign
- 600.00K 6.40M 2.80M
Income Tax - Deferred - Domestic
10.30M 43.20M 29.10M 21.50M
Income Tax - Deferred - Foreign
1.60M 1.60M 2.70M 3.70M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(400.00K) (1.00M) (600.00K) (300.00K)
Consolidated Net Income
69.20M 244.80M 158.60M 93.40M
Minority Interest Expense
- - - -
-
Net Income
69.20M 244.80M 158.60M 93.40M
Net Income Growth
-34.59% +253.76% -35.21% -41.11%
Net Margin Growth
+3.40% +10.91% +6.87% +3.63%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
69.20M 244.80M 158.60M 93.40M
Preferred Dividends
- - - -
-
Net Income Available to Common
69.20M 244.80M 158.60M 93.40M
EPS (Basic)
1.4387 5.0788 3.2701 1.9218
EPS (Basic) Growth
-34.73% +253.01% -35.61% -41.23%
Basic Shares Outstanding
48.10M 48.20M 48.50M 48.60M
EPS (Diluted)
1.4239 5.0474 3.2567 1.9139
EPS (Diluted) Growth
-34.73% +254.48% -35.48% -41.23%
Diluted Shares Outstanding
48.60M 48.50M 48.70M 48.80M
EBITDA
254.50M 314.10M 342.20M 415.70M
EBITDA Growth
-6.91% +23.42% +8.95% +21.48%
EBITDA Margin
+12.50% +14.00% +14.83% +16.18%

Snapshot

Average Recommendation BUY Average Target Price 116.00
Number of Ratings 5 Current Quarters Estimate 0.934
FY Report Date 12 / 2025 Current Year's Estimate 4.233
Last Quarter’s Earnings 1.56 Median PE on CY Estimate N/A
Year Ago Earnings 3.02 Next Fiscal Year Estimate 4.846
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 4 6 6
Mean Estimate 0.93 0.53 4.23 4.85
High Estimates 1.03 0.59 4.30 5.39
Low Estimate 0.78 0.48 4.10 4.48
Coefficient of Variance 8.83 9.62 1.75 6.13

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 5
OVERWEIGHT 1 1 1
HOLD 0 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Overweight Buy

Insider Actions for Arcosa Inc - ACA

Date Name Shares Transaction Value
Aug 13, 2025 Bryan P. Stevenson CLO & Asst Corp Sec. 38,089 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.02 per share 3,771,572.78
Aug 13, 2025 Bryan P. Stevenson CLO & Asst Corp Sec. 37,589 Bona fide gift 0.00
Apr 2, 2025 John W. Lindsay Director 7,384 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 Antonio Carrillo Rule President & CEO; Director 4,874 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2025 Antonio Carrillo Rule President & CEO; Director 433,283 Open market or private purchase of non-derivative security Non-derivative transaction at $79.05 per share 34,251,021.15
Mar 6, 2025 Rhys J. Best Director 58,195 Open market or private purchase of non-derivative security Non-derivative transaction at $79.84 per share 4,646,288.80
Feb 27, 2025 Jess E. Collins Group President 15,665 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Gail M. Peck Chief Financial Officer 71,569 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Kerry S. Cole Group President 21,473 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Reid S. Essl Group President 87,283 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Eric Hurst VP Controller (PAO) 4,485 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Arcosa Inc in the News